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Background: Although exercise has been addressed as an adjuvant treatment for anxiety, depression and cancer-related
symptoms, limited studies have evaluated the effectiveness of exercise in patients with lung cancer.
Methods: We recruited 116 patients from a medical centre in northern Taiwan, and randomly assigned them to either a walking-
exercise group (n¼ 58) or a usual-care group (n¼ 58). We conducted a 12-week exercise programme that comprised home-based,
moderate-intensity walking for 40min per day, 3 days per week, and weekly exercise counselling. The outcome measures included
the Hospital Anxiety and Depression Scale and the Taiwanese version of the MD Anderson Symptom Inventory.
Results: We analysed the effects of the exercise programme on anxiety, depression and cancer-related symptoms by using a
generalised estimating equation method. The exercise group patients exhibited significant improvements in their anxiety levels
over time (P¼ 0.009 and 0.006 in the third and sixth months, respectively) and depression (P¼ 0.00006 and 0.004 in the third and
sixth months, respectively) than did the usual-care group patients.
Conclusions: The home-based walking exercise programme is a feasible and effective intervention method for managing anxiety
and depression in lung cancer survivors and can be considered as an essential component of lung cancer rehabilitation.
The proportion of lung cancer survivors is growing worldwide
(Forman et al, 2013) and in Taiwan (Ministry of Health and
Welfare, 2013). Patients with lung cancer frequently experience
psychological problems, such as anxiety and depression. The
prevalence rates of anxiety and depression in lung cancer survivors
are 34% and 33%, respectively (Hopwood and Stephens, 2000).
Lung cancer is a highly symptomatic disease, involving symptoms
such as pain, fatigue, sleep disturbance, shortness of breath and dry
mouth during the treatment period and in the follow-up stage
(Wang et al, 2010; Pan et al, 2012). Anxiety, depression and
cancer-related symptoms might limit the functional ability and
impair the quality of life (QOL) in lung cancer survivors.
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Although exercise provides several benefits for patients with
cancer, the effects of exercise on anxiety, depression and cancer-
related symptoms have been inconsistently reported in various
studies. As demonstrated by three previous studies, exercise can
reduce both anxiety and depression (Mehnert et al, 2011), only
anxiety (Blacklock et al, 2010), or only depression (Midtgaard et al,
2011) in patients with breast cancer and other cancers. However,
four previous studies have indicated that exercise intervention is
ineffective in reducing both anxiety and depression in the patient
population with breast, lung, colorectal and other cancers (Temel
et al, 2009; Duijts et al, 2012; Jacobsen et al, 2013; Lin et al, 2014).
Regarding cancer-related symptoms, a study with a small sample
size demonstrated that exercise can reduce the symptoms of
advanced lung cancer such as coughing and dyspnoea (Temel et al,
2009). Conversely, two other studies have indicated that exercise
has no effect on cancer-related symptoms such as fatigue and sleep
disturbance in patients with breast, colorectal or ovarian cancer
(Dodd et al, 2010; Lin et al, 2014). These studies have involved the
use of various exercise modalities (e.g., brisk walking, running,
cycling, swimming and resistance training), including various
exercise modes with varying frequency, intensity and duration,
thereby resulting in inconsistent conclusions.
Schmitz et al (2010) suggested that patients with cancer must
perform moderate-intensity aerobic exercises such as walking and
cycling for 20–60min per session for 3–5 days per week to improve
mood and QOL and reduce fatigue (Schmitz et al, 2010). Walking
is strongly recommended for patients with pulmonary diseases
because it is involved in most activities of daily living (ADLs)
(American College of Sports Medicine, 2006). In addition, walking
is the most preferred exercise of patients with lung cancer because
it is flexible and can be performed alone in Taiwanese patients with
lung cancer (Lin et al, 2013).
A home-based, moderate-intensity walking programme can
reduce anxiety (Mock et al, 1997; Courneya et al, 2003), depression
(Courneya et al, 2003) and the severity of cancer-related symptoms
(Mock et al, 1997; Courneya et al, 2003; Mock et al, 2005; Chang
et al, 2014) in patients with breast and colorectal cancers; however,
research on the effects of home-based walking exercise on patients
with lung cancer remains limited. The current study aimed to
determine the effectiveness of a 12-week home-based walking-
exercise programme in managing anxiety, depression and the
severity of cancer-related symptoms in Taiwanese patients with
lung cancer. We hypothesised the walking-exercise group to be
superior to the usual-care group regarding patient-rated anxiety,
depression and the severity of cancer-related symptoms. According
to a thorough literature review, this is the first study that
investigates the psychological effects of home-based walking
exercise on patients with lung cancer.
MATERIALS AND METHODS
Research design and study sample. We conducted a parallel,
randomised, controlled and single-centre trial with a home-based
walking-exercise group and a usual-care group. Participants were
recruited from a medical centre in northern Taiwan with the
following eligibility criteria: patients who were diagnosed with
primary lung cancer, were aged X18 years, were able to speak
Mandarin or Taiwanese and who exhibited no cognitive impair-
ment. A patient was excluded if he or she (1) had engaged in
regular exercise (150min per week, moderate intensity) or had
received cognitive behaviour therapy in the past 6 months; (2) had
been diagnosed with congestive heart disease; (3) had been
diagnosed with lower limb orthopaedic diseases that restrict
walking ability; or (4) had been diagnosed with repeated onset of
depression. The study protocol was approved by the Institutional
Review Board of Taipei Veterans General Hospital (Taipei,
Taiwan).
Procedure. When the patients visited a physician at the outpatient
department of this hospital and agreed to participate in the study,
they were referred to the researcher, who explained the study
procedure. After the participants received an explanation and
provided informed consent, they underwent a baseline assessment
(T1) at the hospital. The researchers used a computer to generate a
randomisation list featuring four-person blocks before performing
the experiments; the lists of the various groups were then sealed
inside opaque envelops. During pretest data collection, one of the
researchers opened the envelopes and randomly assigned partici-
pants to the walking-exercise or the usual-care group. Follow-up
questionnaires were distributed by post during the third (T2) and
sixth (T3) months. On study completion, the usual-care group
participants received a walking-exercise booklet by post.
Intervention. The exercise programme was a 12-week home-
based, moderate-intensity walking-exercise programme consisting
of 40min per session, 3 sessions per week, and weekly exercise
counselling. During the enrolment period, we offered a walking-
exercise booklet to the participants, and used its contents to
instruct the patients regarding the mode, intensity and frequency
of exercise; pulse-rate measurement; Borg’s rating of perceived
exertion (RPE) scale (6–20) (Borg, 1998); prevention of sports
injuries; and the time point of terminating the exercise. Each
participant was instructed to achieve a target heart rate of 60–80%,
based on the Karvonen method (Karvonen et al, 1957), and a score
of 13–15 on the RPE scale. In addition, the aforementioned
researcher conducted weekly telephone interviews with the
participants to discuss their exercise experiences and remind them
to complete the exercise records. When a participant had not
exercised for a minimum of 3 days because of reasons other than
physical illness, the exercise programme content was reviewed with
the participant, and he or she was encouraged to continue
exercising. Because we contacted the participants to teach them the
walking exercise, and also collected data during the follow-up
periods, blinding of both the patients and the researcher was
impossible. To compensate, three data (T1, T2 and T3) key-in
procedures were performed by a research assistant to obscure
patient identification data (e.g., names) before submitting the data
to the researchers for subsequent statistical analyses. In addition, to
control the research quality, the progress of this study was reported
annually to the Institutional Review Board of Taipei Veterans
General Hospital (Taipei, Taiwan). Project aspects, such as
research design and intervention measures, were not modified
during the research period.
Study measures. The patients’ demographic data, including age,
sex, educational attainment, employment status and marital status,
were obtained using a baseline questionnaire. The cancer stage and
current treatment records were acquired from the baseline medical
records of the patients. The primary outcomes were anxiety and
depression, as assessed using the Hospital Anxiety and Depression
Scale (HADS) (Zigmond and Snaith, 1983), that comprises seven
items each for anxiety and depression. Each item of the anxiety
subscale (HADS-A) and the depression subscale (HADS-D) was
scored on a 4-point scale from 0 (not at all) to 3 (very much so).
Higher scores indicated higher anxiety or depression levels.
Subscale scores of X11 were considered to indicate a ‘definite
case’, whereas subscale scores of 8 to 10 and 0 to 7 were considered
to be a ‘suspicious case’ and a ‘noncase’, respectively, of anxiety or
depression (Zigmond and Snaith, 1983). This scale is a reliable tool,
and is widely used to assess patients with cancer (Feinstein et al,
2010; Duijts et al, 2012). We anticipated that the effects of exercise
on anxiety and depression would be observable during the third
month (T2) after intervention.
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The secondary outcomes comprised the severity of cancer-
related symptoms including pain, fatigue, nausea, sleep distur-
bance, sadness, shortness of breath, difficulty remembering, poor
appetite, drowsiness, dry mouth, distress, vomiting and numbness
that were assessed using the Taiwanese version of the MD Anderson
Symptom Inventory (MDASI-T) (Lin et al, 2007). MDASI-T
comprises 13 single-item measures of symptom intensity in the past
24 h, each of which is scored on an 11-point scale from 0 (not at all)
to 10 (as bad as you can imagine). The symptom severity score was
an average of these 13 symptom items: higher scores indicated
greater symptom intensity. The questionnaire was validated for a
sample of Taiwanese patients with cancer, which exhibited a strong
Cronbach’s a, with an internal consistency of 0.89 and a test–retest
reliability of 0.97 (Lin et al, 2007). The MDASI-T scale is a reliable
tool and has been used to assess Taiwanese patients with cancer
(Chang and Lin, 2009; Pan et al, 2012).
Statistical analysis and sample size calculation. Based on the
results from the eight participants in the pilot study, the mean
(±s.d.) HADS-A scores of the walking-exercise and usual-care
groups were 3.50 (3.42) and 5.75 (3.78), respectively, after
the 12-week home-based walking exercise programme. Using
the G*Power software (version 3.1.0) (Erdfelder et al, 2009) for
repeated measures, and with a significance level of 0.05, an
effect size of 0.30, a power of 0.8 and a correlation of 0.8, the
sample size was estimated as 40 patients for each group. Based
on an assumed dropout rate of 30%, 104 patients were considered
adequate.
We used an intention-to-treat (ITT) approach. All statistical
analyses were conducted using the IBM Statistical Package for the
Social Sciences (SPSS) (Version 20) for Windows (IBM, Somers,
NY, USA). We used t-test or w2-test to determine the differences in
the demographic data and the disease characteristics or outcome
variables at baseline between the non-dropout patients (measured
at all three time points) and the dropout patients (measured at one
or two time points only). We used descriptive statistics to analyse
the demographic data and disease characteristics as well as anxiety,
depression and cancer-related symptom severity. We compared the
baseline values for the demographic data, disease characteristics
and outcome measures between the walking-exercise and usual-
care groups by using the t-test or the w2-test.
We used a general linear model to evaluate the mean and s.d.
values, and the differences between the group outcomes (anxiety,
depression and cancer-related symptom severity) at the baseline,
third month and sixth month, and to model the outcomes (anxiety,
depression and cancer-related symptom severity) as a function of
the main effect (group differences) and main time effect. Both
stability and repeated relationship analyses were conducted using
generalised estimation equations (GEE). We added an interaction
term (group difference time) to each model to investigate the
cooperative effect of exercise and time. The changes in study
outcome values (anxiety, depression and cancer-related symptom
severity) from baseline to follow-up periods (third and sixth
months) were expressed in both the walking-exercise and usual-
care groups. We used the general linear model to model the
outcomes (number of patients with anxiety and depression
according to the clinical cutoff point) as a function of the main
effect (group differences). Both stability and repeated relationship
analyses were conducted using GEE. An interaction term (group
difference time) was added to each model to investigate the
interactive effects of exercise and time. All the tests involved a two-
sided significance level of a¼ 0.05.
Trial Registry: www.chictr.org; Identifier: ChiCTR-TRC-
14004756.
Assessed for eligibility based on physician referral (n=120)
Randomised (n=116)
Excluded (n=4)
Not interesting (n=3), too busy (n=1)
Walking group (n=58) Usual-care group (n=58)
Dropouts (n=8)
Not interested (n=4), bone pain (n=2),
travelling (n=1), 
care husband for hospitalisation (n=1)
Dropouts (n=7)
Not interesting (n=4), too busy
(n=2), unspecified (n=1)
Assessed at 3 months (n=50) Assessed at 3 months (n=51)
Dropouts (n=6)
Not interested (n=2), too busy (n=2),
heart disease (n=1), 
hospitalised (n=1)
Dropouts (n=4) 
Not interested (n=1), too busy (n=2),
hospitalised (n=1)
Assessed at 6 months (n=44) Assessed at 6 months (n=47)
Analysed (n=58) Analysed (n=58)
Figure 1. CONSORT (Consolidated Standards of Reporting Trials) diagram showing the flow of participants through the trial.
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RESULTS
Participant characteristics. Participants were recruited from
March 2010 to November 2012. As shown in Figure 1, 120 eligible
patients from the outpatient department were referred by two
physicians for study enrolment. After face-to-face consultations
during which the study protocols and aims were explained to the
patients in the hospital, four patients were excluded because they
were uninterested or too busy to participate. As shown in Table 1,
the sample comprised 116 patients (54 men and 62 women) aged
37–88 years, with a mean age of 64.16±10.89 years. Most
participants were married and unemployed; 65% of participants
had stage 1 lung cancer, and 54% had undergone operations. No
statistically significant differences emerged in the baseline demo-
graphic data and disease characteristics between the walking and
the usual-care groups (P40.050). In addition, no significant
differences emerged in the amount of baseline physical activity
between both groups.
Missing value analysis. Measurements were recorded at 3 time
points: the measurements for 91 (78.4%) participants (non-
dropout patients) were recorded at all 3 time points, but for 25
participants (dropout patients), the measurements were recorded
at 1 or 2 time points only, after which the patients dropped out.
The dropout patients were older (68.14 vs 62.90 years, P¼ 0.026)
and exhibited higher baseline depression scores (6.57 vs 4.77,
P¼ 0.023) than did the non-dropout patients.
Overall, 14 (24.1%) and 11 (19.0%) participants dropped out in
the walking and usual-care groups, respectively, but the difference
that was observed in the dropout rates between the two groups
(x2¼ 0.450, P¼ 0.498) was nonsignificant. The total attrition rate
was 21.6%, and the reasons for dropping out are presented in
Figure 1.
Protocol adherence. Of the 58 patients in the walking-exercise
group, 26 (44.8%) completed the 12-week programme, and 36
(62%) completed at least half of the 12-week programme. The
mean value of the number of completed walking-exercise sessions
was 21.48 (s.d.¼ 15.80). The exercise adherence rate was 59.7%.
The participants did not complete the entire session because they
either dropped out (n¼ 10), perceived discomfort (n¼ 12), lacked
motivation (n¼ 6) or were too busy (n¼ 4). No exercise-related
adverse effects were observed in the walking-exercise group during
the study period.
Intervention effects on anxiety, depression and cancer-related
symptoms. The mean anxiety scores at baseline were 4.59
(s.d.¼ 3.46) and 3.50 (s.d.¼ 3.91) in the walking-exercise and
usual-care groups, respectively; no significant intergroup differ-
ences were observed (t¼ 1.47, P¼ 0.144; Table 2). The mean
anxiety score of the walking-exercise group declined by 1.04 points
between the baseline and the sixth month and was compared using
the general linear model; however, this change was not statistically
significant. In contrast, the mean anxiety score of the usual-care
group at the third month (mean difference¼ 1.72, P¼ 0.012)
increased significantly from baseline, and then remained stable
until the sixth month (Table 2). The anxiety scores of the walking-
exercise group declined by 0.63 points at the third month and by
1.03 points at the sixth month compared with the corresponding
scores of the usual-care group, although these differences were not
statistically significant (Table 2). Furthermore, a significant
interaction term (group difference time) of the model at the
third month (b¼  1.80, P¼ 0.009) and sixth month (b¼  2.18,
P¼ 0.006) verified that the walking exercise programme effectively
reduced anxiety levels over time (Table 3 and Figure 2).
The mean depression scores at baseline were 5.67 (s.d.¼ 3.57)
and 4.74 (s.d.¼ 3.73) in the walking-exercise and usual-care
groups, respectively. No significant intergroup differences were
observed (t¼ 1.37, P¼ 0.173). The mean depression scores of the
walking-exercise group gradually declined from baseline to the
third and sixth months (Table 2), although these changes revealed
no statistical significance in these scores. However, the mean
depression scores of the usual-care group at the third month
increased significantly from baseline (mean difference¼ 2.63,
P¼ 0.0004), revealing a marginally significant increase at sixth
month from baseline (mean difference¼ 1.35, P¼ 0.071; Table 2).
In addition, significant differences were observed at the third and
sixth months between the walking and the usual-care groups
(mean difference¼  2.45, P¼ 0.001; mean difference¼  1.68,
P¼ 0.035, respectively; Table 2). Furthermore, a significant
interaction term (group difference time) of the model at the
third (b¼  3.31, P¼ 0.00006) and sixth (b¼  2.57, P¼ 0.004)
months revealed that the participants engaging in walking
exhibited further reductions in depression over time. These results
indicated that the walking-exercise programme effectively reduced
depression (Table 3 and Figure 3).
At baseline, the mean symptom scores were 1.93 (s.d.¼ 1.45)
and 2.04 (s.d.¼ 1.48) for the walking-exercise and usual-care
groups, respectively. Because the value of presentation was skewed,
the median and interquartile ranges (IQRs) were considered
instead of the mean and s.d. values. The median symptom scores
were 1.62 (IQR¼ 0.90–3.10) and 2.11 (IQR¼ 0.83–2.92) for the
walking-exercise and the usual-care groups, respectively. No
significant intergroup differences were observed (t¼  0.41,
P¼ 0.683). Moreover, the mean symptom score of the walking-
exercise group declined from the baseline to the third month
(mean difference¼ 0.43, P¼ 0.137) and remained stable from the
Table 1. Demographic data and disease characteristics for all
participants categorised based on the two groups (n¼116)
Variables
Walking-
exercise
group, n¼58
Usual-care
group,
n¼58 P-valuea
Age (years)
Mean (s.d.) 64.76 (11.28) 63.57 (10.54) 0.559
Education (years)
Mean (s.d.) 10.66 (4.73) 10.62 (4.66) 0.969
Sex (n, %)
Male 26 (44.8) 28 (48.3) 0.710
Female 32 (55.2) 30 (51.7)
Employment (n, %)
No 42 (72.4) 34 (58.6) 0.118
Yes 16 (27.6) 24 (41.4)
Marital status (n, %)
Married 48 (82.8) 48 (82.8) 1
Not married/single 10 (17.2) 10 (17.2)
Cancer stage (n, %)
1 34 (58.6) 41 (70.7) 0.681
2 5 (8.6) 4 (6.9)
3 6 (10.4) 5 (8.6)
4 5 (8.6) 4 (6.9)
Unknown 8 (13.8) 4 (6.9)
Current treatment (n, %)
No treatment 19 (32.8) 17 (29.3) 0.889
Operation 30 (51.8) 33 (57.0)
Chemotherapy 1 (1.7) 0 (0.0)
Radiotherapy 2 (3.4) 2 (3.4)
Target therapy 4 (6.9) 5 (8.6)
Chemotherapy and
radiotherapy
2 (3.4) 1 (1.7)
aThe P-values are based on w2 analyses for categorical variables and t-tests for continuous
variables.
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third to the sixth month (mean difference¼ 0.04, P¼ 0.896).
However, the mean symptom scores of the usual-care group at the
third (mean difference¼ 0.04, P¼ 0.886) and sixth (mean
difference¼ 0.30, P¼ 0.313) months remained unaltered from
the baseline (Table 2). A marginally significant difference was
observed between both the groups at the third month (1.50 vs 2.08
points, P¼ 0.053; Table 2). However, the model of the interaction
term (group difference time) at the third month was marginally
significant (b¼  0.43, P¼ 0.050) but did not achieve statistical
Table 2. Intention-to-treat analysis: mean and s.d. values and outcome differences between both groups at baseline and at third
and sixth months according to the general linear model
Baseline Thirrd month Sixth month
Outcome by
group
No. of
patients Mean s.d.
No. of
patients Mean s.d.
Difference
between groups
(95% CI) P-value
No. of
patients Mean s.d.
Difference
between groups
(95% CI) P-value
Anxiety
Walking group 58 4.59 3.46 50 4.59 2.63 0.63 0.379 44 3.55 3.34  1.03 0.168
Usual-care groupa 58 3.50 3.91 51 5.22 4.01 (2.04; 0.78) 47 4.57 3.96 ( 2.49;0.43)
Depression
Walking group 58 5.67 3.57 50 4.92 3.14 2.45 0.001* 44 4.41 3.79  1.68 0.035*
Usual-care groupa 58 4.74 3.73 51 7.37 4.52 (3.95; 0.95) 47 6.09 4.11 (3.23;  0.12)
Symptoms
Walking group 58 1.93 1.45 50 1.50 1.27 0.58 0.053 44 1.54 1.68  0.21 0.512
Usual-care groupa 58 2.04 1.48 51 2.08 1.65 (1.18; 0.01) 47 1.74 1.55 (0.82; 0.41)
Abbreviation: CI¼ confidence interval. *P o0.05.
aUsual-care group is reference group.
Table 3. Results of the generalised linear modela regarding
the effects of walking exercise on anxiety, depression and
cancer-related symptoms (n¼ 116)
Variables b s.e. P-value
Anxiety
Group (WG vs UG) 1.09 0.68 0.110
Time
Baseline Reference
Third month 1.75 0.52 0.001*
Sixth month 1.07 0.53 0.042*
Group time
Groupbaseline Reference
Group third month  1.80 0.69 0.009*
Group sixth month  2.18 0.79 0.006*
Depression
Group (WG vs UG) 0.93 0.67 0.166
Time
Baseline Reference
Third month 2.66 0.59 0.00001*
Sixth month 1.44 0.58 0.013*
Group time
Groupbaseline Reference
Group third month  3.31 0.83 0.00006*
Group sixth month  2.57 0.88 0.004*
Cancer-related symptoms
Group (WG vs UG)  0.11 0.27 0.679
Time
Baseline Reference
Third month  0.03 0.15 0.819
Sixth month  0.38 0.18 0.039*
Group time
Groupbaseline Reference
Group third month  0.43 0.22 0.050
Group sixth month  0.03 0.30 0.910
Abbreviations: b¼modelling coefficient; UG¼ usual-care group; WG¼walking-exercise
group. *Po0.05.
aUsing generalised estimation equations for repeated measurements and exchangeable
correlation structure.
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Figure 2. Changes in anxiety subscale scores at baseline and at the
third and sixth months according to the general linear model.
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Figure 3. Changes in depression subscale scores at baseline and at the
third and sixth months according to the general linear model.
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significance at the sixth month (b¼  0.03, P¼ 0.910) (Table 3
and Figure 4). Detailed information is presented in Tables 2 and 3.
Intervention effects on anxiety and depression according to the
clinical cutoff point. A cutoff point of 8 was used to investigate
the clinical significance of the observed changes; the walking-
exercise and usual-care groups revealed similar numbers of definite
and suspicious (scores X8) anxiety cases at baseline (13 vs 8,
P¼ 0.288). Although a significant difference was observed from the
baseline to the third month (a decrease of 4 patients in the
walking-exercise group vs an increase of 9 patients in the usual-
care group, P¼ 0.014), no significant differences were observed
from the baseline to the sixth month (a decrease of 8 patients in the
walking-exercise group vs no decrease in the usual-care group,
P¼ 0.118). A significant interaction term (group difference time)
in the GEE model (Wald x2¼ 6.04, P¼ 0.049) verified that the
walking-exercise programme effectively reduced the number of
patients with anxiety over time (Table 4).
Similarly, when the cutoff point of 8 was used to investigate the
clinical relevance of the observed changes, both the walking-
exercise and usual-care groups revealed a similar number of
definite and suspicious (scores X8) depression cases at baseline
(18 vs 14, P¼ 0.406). Moreover, although a significant difference
was observed from the baseline to the third month (a decrease of
8 patients vs an increase of 9 patients, P¼ 0.001), no significant
differences were observed from the baseline to the sixth month (a
decrease of 5 patients vs an increase of 2 patients, P¼ 0.257). The
significant interaction term (group difference time) in the GEE
model (Wald x2¼ 10.74, P¼ 0.005) indicated that the walking-
exercise programme effectively reduced the number of patients
with depression over time (Table 4).
DISCUSSION
This is the first study to investigate the psychological effects of a
home-based walking-exercise programme on patients with lung
cancer. The trial results support the hypothesis that a home-based
walking exercise exerts positive effects on anxiety and depression in
patients with lung cancer. These results are consistent with those
obtained in previous studies on patients with colorectal and breast
cancer (Mock et al, 1997; Courneya et al, 2003; Mehnert et al,
2011). In addition, our results indicate that the psychological
benefits of exercise observed in other cancer populations apply to
patients with lung cancer as well. However, a previous study
(Duijts et al, 2012) conducted a 12-week, home-based, self-directed
exercise programme (e.g., swimming and running) for patients
with breast cancer and reported negative results; this may have
been caused by 36% lower exercise adherence rates. Similarly,
another study (Jacobsen et al, 2013) adopted a home-based walking
exercise programme that included a 12-min video and an exercise
booklet, and failed to reduce anxiety and depression in patients
with cancer undergoing chemotherapy. We suggest that research-
ers implement weekly telephonic interviews and personal discus-
sions with patients to increase their adherence rate, and also offer
face-to-face instructions instead of videos when conducting a
home-based exercise intervention study.
Regarding exercise intensity, because of the constraints of our
research budget, we used both the heart rate and Borg’s RPE that
were measured by the patients themselves; however, accurate heart
rate detection can be challenging for elderly people. We suggest
that a future study with a larger budget use watch-like heart rate
monitors to facilitate precise heart rate detection; this would reduce
the measurement error when patients measure their own heart rate
as well as the patient load for heart rate measurement, particularly
on elderly patients. Moreover, in this study, three patients
presented with postoperative dyspnoea; therefore, they could not
endure moderate-intensity exercises during the first and second
weeks of the walking-exercise programme, but adapted gradually
after the second week. A previous study reported that light-
intensity exercise has an antianxiety effect on breast cancer
survivors (Blacklock et al, 2010). Therefore, in future studies,
moderate-intensity exercise should be modified to light-intensity
exercise for patients with dyspnoea.
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Figure 4. Changes in symptom severity at baseline and at the third
and sixth months according to the general linear model.
Table 4. Effects of walking exercise on the Hospital Anxiety and Depression Scale (HADS) outcome variables according to the
clinical cutoff point at baseline and at third and sixth months (general linear model)
Pretest,a case
number (%)
Third month,
case number (%)
Sixth month,
case number (%)
Outcome variables X8 o8 X8 o8
Wald
v2
P-value of
group time X8 o8
Wald
v2
P-value of
group time
Overall
of
Wald v2
Overall
P-value of
group time
Anxiety 6.04 0.014* 2.45 0.118 6.04 0.049*
Walking-exercise group 13 (22.4) 45 (77.6) 9 (18.4) 40 (81.6) 5 (11.4) 39 (88.6)
Usual-care groupa 8 (13.8) 50 (86.2) 17 (34.7) 32 (65.3) 8 (17.0) 39 (83.0)
Depression 10.26 0.001* 1.28 0.257 10.74 0.005*
Walking-exercise group 18 (31.0) 40 (69.0) 10 (20.4) 39 (79.6) 13 (29.5) 31 (70.5)
Usual-care groupa 14 (24.1) 44 (75.9) 23(46.9) 26(53.1) 16 (34.0) 31 (66.0)
Using generalised estimation equations for repeated measurements and (AR1) correlation structure. *Po0.05.
aReference group.
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Regarding the effects of exercise on symptom severity, no
substantial reduction was observed in the symptoms. This result is
consistent with the results of two previous studies (Dodd et al,
2010; Lin et al, 2014), wherein neither supervised exercise nor
home-based exercise alleviated the cancer-related symptoms in
patients with breast, colorectal and ovarian cancer. Although no
significant difference was observed in the severity of symptoms
between the two groups over time, the symptom scores of the
walking-exercise group were marginally significantly lower than
those of the usual-care group (1.50 vs 2.08 points, respectively,
P¼ 0.053) in the third month. A possible reason that symptoms
were not relieved in this study is the floor effect, because the
symptom scores of the participants averaged 2.0 points at baseline,
indicating mild symptoms.
In the walking-exercise group, 14 (24.1%) patients dropped out,
and 11 (19.0%) patients in the usual-care group dropped out. The
patients who dropped out exhibited higher depression scores than
did the non-dropout patients. This finding is similar to that of a
study on patients enrolled in a cardiac rehabilitation programme;
the depression status served as a predictor of the number of
exercise sessions completed and the dropout rate (Glazer et al,
2002). We suggest that health-care providers conduct regular
follow-ups of the depression status of patients, and encourage them
to continue exercising when conducting an exercise programme.
The strengths of this trial include it being the first home-based
walking-exercise, randomised controlled trial to focus on Taiwa-
nese patients with lung cancer; the 97% recruitment rate; and the
adoption of a feasible and flexible exercise programme. However,
this study had several limitations. First, the registration was
retrospective and may have created risk when changing the study
design and analysis after data collation. To control the research
quality, the progress of this study was reported annually to the
Institutional Review Board of Taipei Veterans General Hospital
(Taipei, Taiwan). Project aspects such as research design and
intervention measures were not modified during the research
period. Second, although lack of blinding is inevitable in this type
of study, it may have induced a placebo effect on the patients and
an observational bias among the researchers; therefore, the
outcome assessors should be trained in standardised testing
procedures to reduce bias. Third, three patients reported that they
could not endure the moderate-intensity exercises during the first
and second weeks; this negatively affected the intervention fidelity
and possibly diluted the intervention effect. Other study limitations
included the use of a single centre to recruit patients, the lack of
blinding and the heterogeneity of this patient population. This
home-based walking-exercise programme warrants adoption in
lung cancer rehabilitation because of its connection with ADLs.
In summary, this paper is the first to document evidence
regarding the feasibility and effectiveness of walking-exercise
training programmes in patients with lung cancer. The study
results suggest that home-based walking exercise can reduce
anxiety and depression, and elucidate the critical role of exercise in
the rehabilitation of patients with cancer. Health-care team
members must comprehend and consider exercise as a supportive
care intervention for lung cancer survivors.
ACKNOWLEDGEMENTS
We thank all participants in this study. This study was supported
by NSC 100-2314-B-038-012-MY3(3-3).
CONFLICT OF INTEREST
The authors declare no conflict of interest.
REFERENCES
American College of Sports Medicine (2006) ACSM’s Guidelines for Exercise
Testing and Prescription. 7th edn. (Lippincott Williams & Wilkins:
Philadelphia.
Blacklock R, Rhodes R, Blanchard C, Gaul C (2010) Effects of exercise
intensity and self-efficacy on state anxiety with breast cancer survivors.
Oncol Nurs Forum 37(2): 206–212.
Borg G (1998) Borg’s Perceived Exertion and Pain Scales. Human Kinetics:
Champaign, IL.
Chang JA, Lin CC (2009) A longitudinal study of the role of patient-reported
outcomes on survival prediction of palliative cancer inpatients in Taiwan.
Support Care Cancer 17(10): 1285–1294.
Chang NW, Lin KC, Lee SC, Chan JYH, Lee YH, Wang KY (2014) Effects of
an early postoperative walking exercise programme on health status in
lung cancer patients recovering from lung lobectomy. J Clin Nursing
23(23-24): 3391–3402.
Courneya KS, Friedenreich CM, Quinney HA, Fields ALA, Jones LW,
Fairey AS (2003) A randomized trial of exercise and quality of life in
colorectal cancer survivors. Eur J Cancer Care 12(4): 347–357.
Dodd MJ, Cho MH, Miaskowski C, Painter PL, Paul SM, Cooper BA, Duda J,
Krasnoff J, Bank KA (2010) A randomized controlled trial of home-based
exercise for cancer-related fatigue in women during and after
chemotherapy with or without radiation therapy. Cancer Nurs 33(4):
245–257.
Duijts SF, van Beurden M, Oldenburg HS, Hunter MS, Kieffer JM,
Stuiver MM, Gerritsma MA, Menke-Pluymers MB, Plaisier PW, Rijna H,
Lopes Cardozo AM, Timmers G, van der Meij S, van der Veen H,
Bijker N, de Widt-Levert LM, Geenen MM, Heuff G, van Dulken EJ,
Boven E, Aaronson NK (2012) Efficacy of cognitive behavioral therapy
and physical exercise in alleviating treatment-induced menopausal
symptoms in patients with breast cancer: results of a randomized,
controlled, multicenter trial. J Clin Oncol 30(33): 4124–4133.
Erdfelder E, Faul F, Buchner A, Lang AG (2009) Statistical power analyses
using G*Power 3.1: tests for correlation and regression analyses. Behav Res
Methods 41(4): 1149–1160.
Feinstein MB, Krebs P, Coups EJ, Park BJ, Steingart RM, Burkhalter J, Logue A,
Ostroff JS (2010) Current dyspnea among long-term survivors of
early-stage non-small cell lung cancer. J Thorac Oncol 5(8): 1221–1226.
Forman D, Bray F, Brewster DH, Gombe Mbalawa C, Kohler B, Pin˜eros M,
Steliarova-Foucher E, Waminathan R, Ferlay J (eds) (2013) Cancer
Incidence in Five Continents, Vol. X (electronic version). Retrieved 7 July
2014, from http://ci5.iarc.fr.
Glazer KM, Emery CF, Frid DJ, Banyasz RE (2002) Psychological predictors
of adherence and outcomes among patients in cardiac rehabilitation.
J Cardiopulm Rehabil 22(1): 40–46.
Hopwood P, Stephens RJ (2000) Depression in patients with lung cancer:
prevalence and risk factors derived from quality-of-life data. J Clin Oncol
18(4): 893–903.
Jacobsen PB, Phillips KM, Jim HSL, Small BJ, Faul LA, Meade CD, Thompson L,
Williams Jr CC, Loftus LS, Fishman M, Wilson RW (2013) Effects of
self-directed stress management training and home-based exercise on
quality of life in cancer patients receiving chemotherapy: a randomized
controlled trial. Psychooncology 22(6): 1229–1235.
Karvonen MJ, Kentala E, Mustala O (1957) The effects of training on heart
rate: a longitudinal study. Ann Med Exp Biol Fenn 35(3): 307–315.
Lin CC, Chang AP, Cleeland CS, Mendoza TR, Wang XS (2007) Taiwanese
version of the M. D. Anderson symptom inventory: symptom assessment
in cancer patients. J Pain Symptom Manage 33(2): 180–188.
Lin KY, Shun SC, Lai YH, Liang JT, Tsauo JY (2014) Comparison of the
effects of a supervised exercise program and usual care in patients with
colorectal cancer undergoing chemotherapy. Cancer Nurs 37(2): E21–E29.
Lin YY, Lai YF, Lu HI, Lai YL, Lin CC (2013) Physical activity preferences
among patients with lung cancer in Taiwan. Cancer Nurs 36(2):
155–162.
Mehnert A, Veers S, Howaldt D, Braumann KM, Koch U, Schulz KH (2011)
Effects of a physical exercise rehabilitation group program on anxiety,
depression, body image, and health-related quality of life among breast
cancer patients. Onkologie 34(5): 248–253.
Midtgaard J, Stage M, Møller T, Andersen C, Quist M, Rørth M, Herrstedt J,
Vistisen K, Christiansen B, Adamsen L (2011) Exercise may reduce
depression but not anxiety in self-referred cancer patients undergoing
BRITISH JOURNAL OF CANCER Effectiveness of walking in lung cancer patients
444 www.bjcancer.com |DOI:10.1038/bjc.2014.612
chemotherapy. Post-hoc analysis of data from the ’Body & Cancer’ trial.
Acta Oncol 50(5): 660–669.
Ministry of Health and Welfare (2013) Taiwan Cancer registry annual report,
2010. Retrieved 7 July 2014, from http://www.hpa.gov.tw/BHPNet/Web/
Stat/StatisticsShow.aspx?No=201305060001.
Mock V, Dow KH, Meares CJ, Grimm PM, Dienemann JA, Haisfield-Wolfe ME,
Quitasol W, Mitchell S, Chakravarthy A, Gage I (1997) Effects of exercise on
fatigue, physical functioning, and emotional distress during radiation therapy
for breast cancer. Oncol Nurs Forum 24(6): 991–1000.
Mock V, Frangakis C, Davidson NE, Ropka ME, Pickett M, Poniatowski B,
Stewart KJ, Cameron L, Zawacki K, Podewils LJ, Cohen G, McCorkle R
(2005) Exercise manages fatigue during breast cancer treatment: a
randomized controlled trial. Psychooncology 14(6): 464–477.
Pan HH, Lin KC, Ho ST, Liang CY, Lee SC, Wang KY (2012) Factors related
to daily life interference in lung cancer patients: a cross-sectional
regression tree study. Eur J Oncol Nurs 16(4): 345–352.
Rubin DB (1987) Multiple Imputation for Nonresponse in Surveys.
Wiley & Sons: New York.
Schmitz KH, Courneya KS, Matthews C, Demark-Wahnefried W, Galva˜o DA,
Pinto BM, Irwin ML, Wolin KY, Segal RJ, Lucia A, Schneider CM,
Von Gruenigen VE, Schwartz AL (2010) American College of Sports
Medicine roundtable on exercise guidelines for cancer survivors. Med Sci
Sports Exerc 42(7): 1409–1426.
Temel JS, Greer JA, Goldberg S, Vogel PD, Sullivan M, Pirl WF, Lynch TJ,
Christiani DC, Smith MR (2009) A structured exercise program for
patients with advanced non-small cell lung cancer. J Thorac Oncol 4(5):
595–601.
Wang XS, Shi Q, Williams LA, Mao L, Cleeland CS, Komaki RR, Mobley GM,
Liao Z (2010) Inflammatory cytokines are associated with the
development of symptom burden in patients with NSCLC undergoing
concurrent chemoradiation therapy. Brain, Behav, Immun 24(6): 968–974.
Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale.
Acta Psychiatr Scand 67(6): 361–370.
This work is published under the standard license to publish agree-
ment. After 12 months the work will become freely available and
the license terms will switch to a Creative Commons Attribution-
NonCommercial-Share Alike 3.0 Unported License.
Effectiveness of walking in lung cancer patients BRITISH JOURNAL OF CANCER
www.bjcancer.com |DOI:10.1038/bjc.2014.612 445
